Capricor Therapeutics (CAPR) Accumulated Expenses (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Accumulated Expenses of $3.8 million for Q1 2026, down 10.34% year-over-year from $4.2 million in Q1 2025, and down 75.56% quarter-over-quarter from $15.6 million in Q4 2025.
Capricor Therapeutics (CAPR) Accumulated Expenses (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Accumulated Expenses history runs 11 years deep, the most recent figure standing at $3.8 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 10.34% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 10.34% YoY), while the FY2025 annual figure was $15.6 million, up 509.5% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $3.8 million, down from $15.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $15.6 million in Q4 2025, with the low at $2.6 million in Q4 2024.
- The 3-year median for Accumulated Expenses is $4.2 million (2025), against an average of $6.7 million.
- The sharpest annual moves came in 2025 and 2026: Accumulated Expenses soared 509.5% in 2025, then dropped 10.34% in 2026.
- Capricor Therapeutics' Accumulated Expenses stood at $2.6 million in 2024, then jumped by 509.5% to $15.6 million in 2025, then slumped by 75.56% to $3.8 million in 2026.
- Business Quant data shows CAPR's Accumulated Expenses at $3.8 million in Q1 2026, $15.6 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 15.56 Mn |
| Sep 30, 2025 | 9.93 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Jun 30, 2017 | 1.06 Mn |
| Mar 31, 2017 | 954,789.00 |
| Dec 31, 2016 | 849,469.00 |
| Sep 30, 2016 | 746,564.00 |
| Jun 30, 2016 | 647,815.00 |
| Mar 31, 2016 | 571,152.00 |
| Dec 31, 2015 | 505,363.00 |
| Sep 30, 2015 | 443,682.00 |
| Jun 30, 2015 | 382,001.00 |
| Mar 31, 2015 | 320,346.00 |
| Dec 31, 2014 | 258,639.00 |
| Sep 30, 2014 | 198,256.00 |
| Jun 30, 2014 | 138,165.00 |
| Mar 31, 2014 | 1.52 Mn |